| Recruiting | A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of t Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria | Phase 1 | 2024-08-30 |
| Completed | A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Ulcerative Colitis | Phase 2 | 2024-04-08 |
| Completed | Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic L Amyotrophic Lateral Sclerosis | Phase 2 | 2023-11-09 |
| Unknown | A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbiditie NAFLD, Obesity, Type 2 Diabetes | Phase 4 | 2023-07-20 |
| Recruiting | A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects Wit Chronic Kidney Diseases, Anemia of Chronic Kidney Disease | Phase 4 | 2023-04-20 |
| Completed | A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadil Metastatic Breast Cancer | Phase 3 | 2022-09-26 |
| Completed | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subje Cryopyrin Associated Periodic Syndrome | Phase 2 | 2022-06-01 |
| Completed | A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics I Malaria | Phase 1 | 2021-08-25 |
| Completed | A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Follo Healthy | Phase 1 | 2021-07-12 |
| Completed | Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Followi Healthy | Phase 1 | 2020-12-28 |
| Completed | Desidustat in the Treatment of Chemotherapy Induced Anemia Anemia of Chronic Kidney Disease, Chemotherapy Effect | Phase 1 | 2020-11-11 |
| Terminated | Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) Covid19 | Phase 2 | 2020-08-11 |
| Completed | Desidustat in the Management of COVID-19 Patients COVID-19 | Phase 2 | 2020-07-25 |
| Completed | Desidustat in the Treatment of Anemia in CKD on Dialysis Patients Chronic Kidney Disease Stage 5 on Dialysis | Phase 3 | 2020-01-04 |
| Completed | Desidustat in the Treatment of Anemia in CKD Chronic Kidney Disease Stage 3, Anemia, Chronic Kidney Disease Stage 4 | Phase 3 | 2019-07-20 |
| Completed | Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Admin Diabetes Mellitus | Phase 1 | 2014-10-01 |
| Completed | To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Acne Vulgaris | Phase 3 | 2013-11-01 |
| Suspended | A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers Diabetes | Phase 1 | 2011-12-01 |
| Completed | A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipid Hypertriglyceridemia, Dyslipidemia | Phase 2 | 2011-11-01 |
| Completed | A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Ad Type 2 Diabetes Mellitus | Phase 1 | 2011-02-01 |
| Terminated | A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Obesity, Lipid Disorders | Phase 1 | 2010-02-01 |